Every trade that managers of Biomm SA disclose to CVM (Brazil) is tracked on this page. The company sits in the Health Care sector. 2 insiders have disclosed 634 filings since 23 October 2025.
On the market, 2 insiders bought (45 purchases totalling €3.0M) while 1 insider sold (579 sales totalling €6.1M). Taken together, the sales exceed the purchases by €3.2M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The filings include the largest sale, €2.0M, on 7 November 2025. Those buying include 1 board member and 1 senior executive.
Compared with its exchange (343 companies, median 23 filings), a count of 634 filings is above the norm. The full history, which starts in 2018, counts 552 purchases against 2,605 sales.
The last insider purchase was made public on 9 October 2026, 15 days ago. Between a trade and the moment it shows up on CVM (Brazil), the median delay is 29 days. That lag is the time during which only the insider knows about the trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.
In the same sector, recent insider purchases at Dynavox Group AB and EssilorLuxottica also feature in our signals. Source: insider filings from CVM (Brazil). Past trades are no guide to future returns.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
25 of 3300 declarations
Biomm SA is a company listed on the BVMF, specializing in the biotechnology sector. It focuses on developing innovative solutions for health and agriculture.
Purchases our model currently ranks for the recommendations list.
All recommendations